Superluminal Medicines Inc.
Generative biology and chemistry company revolutionizing the speed and accuracy of how medicine is created.
51 employees · est. 2023 · Boston, United States
CrystalsFirst is the older company (2018 vs 2023); Superluminal Medicines Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | CrystalsFirst | Superluminal Medicines Inc. |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2023 |
| Headquarters | ||
| Headquarters | Hamburg, Germany | Boston, United States |
| Employees | ||
| Employees | 18 | 51 larger |
| Industry | ||
| Industry | AI, Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Non Equity Assistance | Series A |
| Total Funding | ||
| Total Funding | $756.60K | $153.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 2 |
| Services | ||
| Services | Not tracked yet | Hyperloop™ Platform, AI/ML Integration, Small Molecule Therapeutics Development, Collaborations with Pharmaceutical Companies |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Healthcare Organizations, Patients with Cardiometabolic Diseases |
| Taxonomy | ||
| Taxonomy | Drug Discovery, Structural Biology, Computational Modelling, Generative AI, Medicinal Chemistry, Crystal Structure, Target Interactions, Rational Design, Hit Expansion, Scaffold Hopping, Compound Generation, Therapeutic Compounds, Innovative Technology, Pharmaceutical Research | Generative Biology, Generative Chemistry, Drug Discovery Platform, Deep Biology Expertise, Big Data Infrastructure, Predict-Design-Test Architecture, Protein Modeling, Pharmacokinetics Prediction, Toxicology Prediction, GPCR Targets, Compound Design, Therapeutic Development, Biotech Innovation, In Silico Modeling |
| Website | ||
| Website | crystalsfirst.com | superluminalrx.com |
About CrystalsFirst
CrystalsFirst is a biotechnology startup with the slogan "Turning Insights Into Medicines." Founded in 2018 and headquartered in Germany, the company is focused on revolutionizing small molecule drug discovery through its proprietary MAGNET platform. This technology integrates structural biology, ge...
About Superluminal Medicines Inc.
Superluminal Medicines Inc. is redefining the landscape of biotechnology and pharmaceuticals with its innovative approach to drug discovery. Based in Boston and founded in 2023, the company swiftly capitalizes on its expertise in generative biology and chemistry to expedite the development of therap...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at CrystalsFirst and Superluminal Medicines Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at CrystalsFirst and Superluminal Medicines... — by email.
Frequently Asked Questions
Compare CrystalsFirst with someone else
Start typing a company name or domain.